Clincosm LogoSign in Get a demo

neoplasm

Showing NaN - NaN of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor Trial in Worldwide (Isatuximab SAR650984, Atezolizumab)

Completed
  • Neoplasm
  • Santa Monica, California
  • +26 more
Jun 8, 2022

Tumor Trial in Houston (SGT-53, Topotecan, Cyclophosphamide)

Suspended
  • Neoplasm
  • SGT-53
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Feb 7, 2022

Cancer, Malignancy, Neoplasia Trial in United States (ASN007: ascending doses, ASN007 RD)

Completed
  • Cancer
  • +18 more
  • ASN007: ascending doses
  • ASN007 RD
  • Tampa, Florida
  • +4 more
Jul 7, 2020

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular Trial in Argentina, United States (ASN002 Dose

Terminated
  • Lymphoma, Large B-Cell, Diffuse
  • +20 more
  • ASN002 Dose Escalation
  • ASN002 RD
  • Tempe, Arizona
  • +13 more
Aug 13, 2018

Tumor Trial in Houston (SGT-94)

Completed
  • Neoplasm
  • SGT-94
  • Houston, Texas
    University of Texas, M.D. Anderson Cancer Center
Apr 24, 2017

Tumor Trial in United States (Escalation cohort: Regorafenib (Stivarga, BAY73-4506) 20 mg, Escalation cohort: Regorafenib

Completed
Has Results
  • Neoplasm
  • Escalation cohort: Regorafenib (Stivarga, BAY73-4506) 20 mg
  • +7 more
  • Los Angeles, California
  • +4 more
Nov 16, 2015

Carcinoma, Non-small-cell Lung, Metastases Trial in United States (ZD1839 (Gefitinib))

Completed
  • Carcinoma
  • +3 more
  • ZD1839 (Gefitinib)
  • Alabaster, Alabama
  • +626 more
Jan 3, 2013